Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Theravance Biopharma (TBPH – Research Report), Voyager Therapeutics (VYGR – Research Report) and Praxis Precision Medicines (PRAX – Research Report).
Theravance Biopharma (TBPH)
TD Cowen analyst Marc Frahm maintained a Hold rating on Theravance Biopharma yesterday and set a price target of $10.00. The company’s shares closed last Monday at $9.58.
According to TipRanks.com, Frahm is a 5-star analyst with an average return of
Currently, the analyst consensus on Theravance Biopharma is a Strong Buy with an average price target of $16.50.
See today’s best-performing stocks on TipRanks >>
Voyager Therapeutics (VYGR)
In a report released yesterday, Phil Nadeau from TD Cowen maintained a Buy rating on Voyager Therapeutics. The company’s shares closed last Monday at $8.48.
According to TipRanks.com, Nadeau is a 4-star analyst with an average return of
Voyager Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $18.75, implying a 121.9% upside from current levels. In a report issued on May 1, Oppenheimer also maintained a Buy rating on the stock with a $18.00 price target.
Praxis Precision Medicines (PRAX)
In a report released yesterday, Ritu Baral from TD Cowen maintained a Buy rating on Praxis Precision Medicines. The company’s shares closed last Monday at $45.19.
According to TipRanks.com, Baral is a 4-star analyst with an average return of
Currently, the analyst consensus on Praxis Precision Medicines is a Strong Buy with an average price target of $135.00, representing a 186.6% upside. In a report issued on April 30, Robert W. Baird also initiated coverage with a Buy rating on the stock with a $117.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TBPH:
